Founded in 1839 in Germany, B. Braun is one of the world’s largest medical technology companies, offering solutions across 18 therapy fields, including dialysis treatment. In the Asia Pacific region, B. Braun operates 80 renal care centres, treating more than 6,450 patients and globally almost 30,000 patients are treated in B. Braun renal care centres. 

With almost 25,000 patients in Australia and 4,700 patients in New Zealand living with end-stage renal disease, centres specialising in dialysis therapy are increasingly crucial to local communities.  

Boris Zjacic, Senior Vice President/Head of Area Central East said, “Diaverum has been privileged to provide renal services in Australia for more than 20 years and, more recently, in New Zealand.  In line with our current strategy, we are consolidating our operations and venturing into new markets.  We are pleased to transfer the ownership of our dialysis centres to B. Braun, a pioneering provider of dialysis technology.”

Mr Manogaran Ayalsamy, the Managing Director of B. Braun Australia & New Zealand / B. Braun Avitum Australia & New Zealand said, “We are proud to have the opportunity to share our expertise in dialysis therapy through this acquisition.  We look forward to providing services of the highest quality and safety standards to serve our patients in Australia and New Zealand.”

The five renal care centres offering haemodialysis treatment are based in Australia at North Melbourne, Greensborough, Toowoomba and Lindfield; and Auckland in New Zealand.